Learn more about the exciting field of intratumoral immunotherapy and OncoSec’s role as a key leader in this emerging space.
Watch the Video
OncoSec to Present at the 9th Annual LD Micro Main Event
OncoSec Announces Key Corporate Initiatives at Inaugural Investor & Analyst Day on November 17, 2016
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016
OncoSec Presents Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2016
December 7 | Los Angeles, CA
9th Annual LD Micro Main Event
Our core technology platform continues to advance through clinical trials for various cancers.
The ImmunoPulse® platform is designed to boost the immune system to recognize and attack tumors.
OncoSec continues to establish relationships with industry leaders to further advance our research.
PDF | 2.0 MB
PDF | 1.0 MB